Metabolism drives function, on both an organismal and a cellular level. In T cell biology, metabolic remodeling is intrinsically linked to cellular development, activation, function, differentiation, and survival. After naive T cells are activated, increased demands for metabolic currency in the form of ATP, as well as biomass for cell growth, proliferation, and the production of effector molecules, are met by rewiring cellular metabolism. Consequently, pharmacological strategies are being developed to perturb or enhance selective metabolic processes that are skewed in immune-related pathologies. Here we review the most recent advances describing the metabolic changes that occur during the T cell lifecycle. We discuss how T cell metabolism can have profound effects on health and disease and where it might be a promising target to treat a variety of pathologies.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Weiner HL, Frenkel D. 1.  2006. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6404–16 [Google Scholar]
  2. Heppner FL, Ransohoff RM, Becher B. 2.  2015. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16358–72 [Google Scholar]
  3. Saltiel AR, Olefsky JM. 3.  2017. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Investig. 1271–4 [Google Scholar]
  4. Mathis D. 4.  2013. Immunological goings-on in visceral adipose tissue. Cell Metab 17851–59 [Google Scholar]
  5. Warburg O. 5.  1925. The metabolism of carcinoma cells. J. Cancer Res. 9148–63 [Google Scholar]
  6. Vander Heiden MG, Cantley LC, Thompson CB. 6.  2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 3241029–33 [Google Scholar]
  7. Mills EL, Kelly B, O'Neill LAJ. 7.  2017. Mitochondria are the powerhouses of immunity. Nat. Immunol. 18488–98 [Google Scholar]
  8. Houten SM, Violante S, Ventura FV, Wanders RJA. 8.  2016. The biochemistry and physiology of mitochondrial fatty acid β-oxidation and its genetic disorders. Annu. Rev. Physiol. 7823–44 [Google Scholar]
  9. Schieber M, Chandel NS. 9.  2014. ROS function in redox signaling and oxidative stress. Curr. Biol. 24R453–62 [Google Scholar]
  10. MacIver NJ, Michalek RD, Rathmell JC. 10.  2013. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31259–83 [Google Scholar]
  11. Brownlie RJ, Zamoyska R. 11.  2013. T cell receptor signalling networks: branched, diversified and bounded. Nat. Rev. Immunol. 13257–69 [Google Scholar]
  12. Saxton RA, Sabatini DM. 12.  2017. mTOR signaling in growth, metabolism, and disease. Cell 168960–76 [Google Scholar]
  13. Yang K, Neale G, Green DR, He W, Chi H. 13.  2011. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12888–97 [Google Scholar]
  14. Cekic C, Sag D, Day YJ, Linden J. 14.  2013. Extracellular adenosine regulates naive T cell development and peripheral maintenance. J. Exp. Med. 2102693–706 [Google Scholar]
  15. Cunningham CA, Bergsbaken T, Fink PJ. 15.  2017. Cutting edge: Defective aerobic glycolysis defines the distinct effector function in antigen-activated CD8+ recent thymic emigrants. J. Immunol. 1984575–80 [Google Scholar]
  16. Wang R, Dillon CP, Shi LZ, Milasta S, Carter R. 16.  et al. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35871–82 [Google Scholar]
  17. Pollizzi KN, Patel CH, Sun IH, Oh MH, Waickman AT. 17.  et al. 2015. mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. J. Clin. Investig. 1252090–108 [Google Scholar]
  18. Boyman O, Sprent J. 18.  2012. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12180–90 [Google Scholar]
  19. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A. 19.  et al. 2017. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature 546158–61 [Google Scholar]
  20. Malissen B, Bongrand P. 20.  2015. Early T cell activation: integrating biochemical, structural, and biophysical cues. Annu. Rev. Immunol. 33539–61 [Google Scholar]
  21. Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. 21.  2016. CD28 costimulation: from mechanism to therapy. Immunity 44973–88 [Google Scholar]
  22. Patel CH, Powell JD. 22.  2017. Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease. Curr. Opin. Immunol. 4682–88 [Google Scholar]
  23. Powell JD, Pollizzi KN, Heikamp EB, Horton MR. 23.  2012. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 3039–68 [Google Scholar]
  24. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA. 24.  et al. 2013. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38225–36 [Google Scholar]
  25. Previte DM, O'Connor EC, Novak EA, Martins CP, Mollen KP, Piganelli JD. 25.  2017. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation. PLOS ONE 12e0175549 [Google Scholar]
  26. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. 26.  2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5818–27 [Google Scholar]
  27. Mak TW, Grusdat M, Duncan GS, Dostert C, Nonnenmacher Y. 27.  et al. 2017. Glutathione primes T cell metabolism for inflammation. Immunity 461089–90 [Google Scholar]
  28. Siska PJ, Kim B, Ji X, Hoeksema MD, Massion PP. 28.  et al. 2016. Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes. J. Immunol. Methods 43851–58 [Google Scholar]
  29. Laniewski NG, Grayson JM. 29.  2004. Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection. J. Virol. 7811246–57 [Google Scholar]
  30. Chandel NS. 30.  2015. Evolution of mitochondria as signaling organelles. Cell Metab 22204–6 [Google Scholar]
  31. Jones RG, Pearce EJ. 31.  2017. MenTORing immunity: mTOR signaling in the development and function of tissue-resident immune cells. Immunity 46730–42 [Google Scholar]
  32. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM. 32.  et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 3151687–91 [Google Scholar]
  33. Verbist KC, Guy CS, Milasta S, Liedmann S, Kaminski MM. 33.  et al. 2016. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature 532389–93 [Google Scholar]
  34. Pollizzi KN, Sun IH, Patel CH, Lo YC, Oh MH. 34.  et al. 2016. Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation. Nat. Immunol. 17704–11 [Google Scholar]
  35. Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA. 35.  2013. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14500–8 [Google Scholar]
  36. Chang C-H, Curtis JD, Maggi LB Jr., Faubert B, Villarino AV. 36.  et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 1531239–51 [Google Scholar]
  37. Tan H, Yang K, Li Y, Shaw TI, Wang Y. 37.  et al. 2017. Integrative proteomics and phosphoproteomics profiling reveals dynamic signaling networks and bioenergetics pathways underlying T cell activation. Immunity 46488–503 [Google Scholar]
  38. Tarasenko TN, Pacheco SE, Koenig MK, Gomez-Rodriguez J, Kapnick SM. 38.  et al. 2017. Cytochrome c oxidase activity is a metabolic checkpoint that regulates cell fate decisions during T cell activation and differentiation. Cell Metab 251254–68.e7 [Google Scholar]
  39. Hukelmann JL, Anderson KE, Sinclair LV, Grzes KM, Murillo AB. 39.  et al. 2016. The cytotoxic T cell proteome and its shaping by the kinase mTOR. Nat. Immunol. 17104–12 [Google Scholar]
  40. Gomes LC, Di Benedetto G, Scorrano L. 40.  2011. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13589–98 [Google Scholar]
  41. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L. 41.  et al. 2006. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126163–75 [Google Scholar]
  42. Hentze MW, Preiss T. 42.  2010. The REM phase of gene regulation. Trends Biochem. Sci. 35423–26 [Google Scholar]
  43. Peng C, Lu Z, Xie Z, Cheng Z, Chen Y. 43.  et al. 2011. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell Proteom. 10M111.012658 [Google Scholar]
  44. Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y. 44.  2011. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 758–63 [Google Scholar]
  45. Nishida Y, Rardin MJ, Carrico C, He W, Sahu AK. 45.  et al. 2015. SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol. Cell 59321–32 [Google Scholar]
  46. Moellering RE, Cravatt BF. 46.  2013. Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 341549–53 [Google Scholar]
  47. Swamy M, Pathak S, Grzes KM, Damerow S, Sinclair LV. 47.  et al. 2016. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat. Immunol. 17712–20 [Google Scholar]
  48. Araujo L, Khim P, Mkhikian H, Mortales C-L, Demetriou M. 48.  2017. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. eLife 6e21330 [Google Scholar]
  49. Chien M-W, Lin M-H, Huang S-H, Fu S-H, Hsu C-Y. 49.  et al. 2015. Glucosamine modulates T cell differentiation through down-regulating N-linked glycosylation of CD25. J. Biol. Chem. 29029329–44 [Google Scholar]
  50. Asano T, Takata K, Katagiri H, Ishihara H, Inukai K. 50.  et al. 1993. The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett 324258–61 [Google Scholar]
  51. Console L, Scalise M, Tarmakova Z, Coe IR, Indiveri C. 51.  2015. N-linked glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane. Biochim. Biophys. Acta 18531636–45 [Google Scholar]
  52. Puleston DJ, Villa M, Pearce EL. 52.  2017. Ancillary activity: beyond core metabolism in immune cells. Cell Metab 26131–41 [Google Scholar]
  53. Mowen KA, David M. 53.  2014. Unconventional post-translational modifications in immunological signaling. Nat. Immunol. 15512–20 [Google Scholar]
  54. Ron-Harel N, Santos D, Ghergurovich JM, Sage PT, Reddy A. 54.  et al. 2016. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab 24104–17 [Google Scholar]
  55. Ma EH, Bantug G, Griss T, Condotta S, Johnson RM. 55.  et al. 2017. Serine is an essential metabolite for effector T cell expansion. Cell Metab 25345–57 Correction. 2017 Cell Metab 25482 [Google Scholar]
  56. MacIver NJ, Blagih J, Saucillo DC, Tonelli L, Griss T. 56.  et al. 2011. The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J. Immunol. 1874187–98 [Google Scholar]
  57. Mayer A, Denanglaire S, Viollet B, Leo O, Andris F. 57.  2008. AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur. J. Immunol. 38948–56 [Google Scholar]
  58. Tamás P, Hawley SA, Clarke RG, Mustard KJ, Green K. 58.  et al. 2006. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J. Exp. Med 2031665–70 [Google Scholar]
  59. Adams WC, Chen Y-H, Kratchmarov R, Yen B, Nish SA. 59.  et al. 2016. Anabolism-associated mitochondrial stasis driving lymphocyte differentiation over self-renewal. Cell Rep 173142–52 [Google Scholar]
  60. Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-Vazquez G. 60.  et al. 2015. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. Immunity 4241–54 [Google Scholar]
  61. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA. 61.  et al. 2011. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331456–61 [Google Scholar]
  62. Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE. 62.  et al. 2016. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45374–88 Correction. 2016 Immunity 45701–3 [Google Scholar]
  63. Rabinovitch RC, Samborska B, Faubert B, Ma EH, Gravel SP. 63.  et al. 2017. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep 211–9 [Google Scholar]
  64. Lee J, Walsh MC, Hoehn KL, James DE, Wherry EJ, Choi Y. 64.  2014. Regulator of fatty acid metabolism, acetyl coenzyme A carboxylase 1, controls T cell immunity. J. Immunol. 1923190–99 [Google Scholar]
  65. Lee JE, Walsh MC, Hoehn KL, James DE, Wherry EJ, Choi Y. 65.  2015. Acetyl CoA carboxylase 2 is dispensable for CD8+ T cell responses. PLOS ONE 10e0137776 [Google Scholar]
  66. Saha AK, Ruderman NB. 66.  2003. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol. Cell Biochem. 25365–70 [Google Scholar]
  67. Hosios AM, Hecht VC, Danai LV, Johnson MO, Rathmell JC. 67.  et al. 2016. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36540–49 [Google Scholar]
  68. Liberti MV, Locasale JW. 68.  2016. The Warburg Effect: How does it benefit cancer cells?. Trends Biochem. Sci. 41211–18 [Google Scholar]
  69. Fox CJ, Hammerman PS, Thompson CB. 69.  2005. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5844–52 [Google Scholar]
  70. Franchi L, Monteleone I, Hao L-Y, Spahr MA, Zhao W. 70.  et al. 2017. Inhibiting oxidative phosphorylation in vivo restrains Th17 effector responses and ameliorates murine colitis. J. Immunol. 1982735–46 [Google Scholar]
  71. Buck MD, O'Sullivan D, Klein Geltink RI, Curtis JD, Chang C-H. 71.  et al. 2016. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 16663–76 [Google Scholar]
  72. O'Sullivan D, van der Windt GJW, Huang SC-C, Curtis JD, Chang C-H. 72.  et al. 2014. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 4175–88 [Google Scholar]
  73. Buck MD, Sowell RT, Kaech SM, Pearce EL. 73.  2017. Metabolic instruction of immunity. Cell 169570–86 [Google Scholar]
  74. Jacobs SR, Herman CE, MacIver NJ, Wofford JA, Wieman HL. 74.  et al. 2008. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 1804476–86 [Google Scholar]
  75. Macintyre AN, Gerriets VA, Nichols AG, Michalek RD, Rudolph MC. 75.  et al. 2014. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab 2061–72 [Google Scholar]
  76. Shi L, Tu BP. 76.  2015. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr. Opin. Cell Biol. 33125–31 [Google Scholar]
  77. Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. 77.  2016. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354481–84 [Google Scholar]
  78. Chang C-H, Qiu J, O'Sullivan D, Buck MD, Noguchi T. 78.  et al. 2015. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 1621229–41 [Google Scholar]
  79. Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X. 79.  et al. 2015. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 1621217–28 [Google Scholar]
  80. Zhao E, Maj T, Kryczek I, Li W, Wu K. 80.  et al. 2016. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nature Immunol 1795–103 [Google Scholar]
  81. Siska PJ, van der Windt GJW, Kishton RJ, Cohen S, Eisner W. 81.  et al. 2016. Suppression of Glut1 and glucose metabolism by decreased Akt/mTORC1 signaling drives T cell impairment in B cell leukemia. J. Immunol. 1972532–40 [Google Scholar]
  82. Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B. 82.  et al. 2015. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun. 66692 [Google Scholar]
  83. Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH. 83.  2016. Coinhibitory pathways in immunotherapy for cancer. Annu. Rev. Immunol. 34539–73 [Google Scholar]
  84. Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV. 84.  et al. 2013. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. . Immunol 141173–82 [Google Scholar]
  85. Phan AT, Doedens AL, Palazon A, Tyrakis PA, Cheung KP. 85.  et al. 2016. Constitutive glycolytic metabolism supports CD8+ T cell effector memory differentiation during viral infection. Immunity 451024–37 [Google Scholar]
  86. van der Windt GJ, O'Sullivan D, Everts B, Huang SC, Buck MD. 86.  et al. 2013. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. PNAS 11014336–41 [Google Scholar]
  87. Gubser PM, Bantug GR, Razik L, Fischer M, Dimeloe S. 87.  et al. 2013. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 141064–72 [Google Scholar]
  88. Balmer ML, Hess C. 88.  2016. Feeling worn out? PGC1α to the rescue for dysfunctional mitochondria in T cell exhaustion. Immunity 45233–35 [Google Scholar]
  89. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC. 89.  et al. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16769–77 [Google Scholar]
  90. Choi BK, Lee DY, Lee DG, Kim YH, Kim S-H. 90.  et al. 2017. 4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation. Cell Mol. Immunol. 14748–57 [Google Scholar]
  91. Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H. 91.  et al. 2001. 4–1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 1671313–24 [Google Scholar]
  92. Balmer ML, Ma EH, Bantug GR, Grählert J, Pfister S. 92.  et al. 2016. Memory CD8+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 441312–24 [Google Scholar]
  93. Bengsch B, Johnson AL, Kurachi M, Odorizzi PM, Pauken KE. 93.  et al. 2016. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion. Immunity 45358–73 [Google Scholar]
  94. Zhang CS, Hawley SA, Zong Y, Li M, Wang Z. 94.  et al. 2017. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548112–16 [Google Scholar]
  95. Hu H, Juvekar A, Lyssiotis CA, Lien EC, Albeck JG. 95.  et al. 2016. Phosphoinositide 3-kinase regulates glycolysis through mobilization of aldolase from the actin cytoskeleton. Cell 164433–46 [Google Scholar]
  96. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ. 96.  et al. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12295–303 [Google Scholar]
  97. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL. 97.  et al. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30832–44 [Google Scholar]
  98. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ. 98.  et al. 2011. Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 1863299–303 [Google Scholar]
  99. Battaglia M, Stabilini A, Roncarolo M-G. 99.  2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 1054743–48 [Google Scholar]
  100. Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L. 100.  et al. 2006. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J. Immunol. 177944–49 [Google Scholar]
  101. Kang J, Huddleston SJ, Fraser JM, Khoruts A. 101.  2008. De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J. Leukoc. Biol. 831230–39 [Google Scholar]
  102. Yang K, Shrestha S, Zeng H, Karmaus PW, Neale G. 102.  et al. 2013. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 391043–56 [Google Scholar]
  103. Heikamp EB, Patel CH, Collins S, Waickman A. 103. , Oh M-H, et al. 2014. The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat. Immunol. 15457–64 [Google Scholar]
  104. Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA. 104.  et al. 2004. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 61122–28 [Google Scholar]
  105. Yang J-Q, Kalim KW, Li Y, Zhang S, Hinge A. 105.  et al. 2016. RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation. J. Allergy Clin. Immunol. 137231–45.e4 [Google Scholar]
  106. Zhao FQ, Keating AF. 106.  2007. Functional properties and genomics of glucose transporters. Curr. Genom. 8113–28 [Google Scholar]
  107. Chornoguz O, Hagan RS, Haile A, Arwood ML, Gamper CJ. 107.  et al. 2017. mTORC1 promotes T-bet phosphorylation to regulate Th1 differentiation. J. Immunol. 1983939–48 [Google Scholar]
  108. Kurobe H, Urata M, Ueno M, Ueki M, Ono S. 108.  et al. 2010. Role of hypoxia-inducible factor 1α in T cells as a negative regulator in development of vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 30210–17 [Google Scholar]
  109. Shehade H, Acolty V, Moser M, Oldenhove G. 109.  2015. Cutting edge: Hypoxia-inducible factor 1 negatively regulates Th1 function. J. Immunol. 1951372–76 [Google Scholar]
  110. Metzler B, Gfeller P, Guinet E. 110.  2016. Restricting glutamine or glutamine-dependent purine and pyrimidine syntheses promotes human T cells with high FOXP3 expression and regulatory properties. J. Immunol. 1963618–30 [Google Scholar]
  111. Klysz D, Tai X, Robert PA, Craveiro M, Cretenet G. 111.  et al. 2015. Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation. Sci. Signal. 8ra97 [Google Scholar]
  112. Xu T, Stewart KM, Wang X, Liu K, Xie M. 112.  et al. 2017. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548228–33 [Google Scholar]
  113. Abdel Rahman AM, Ryczko M, Pawling J, Dennis JW. 113.  2013. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS Chem. Biol. 82053–62 [Google Scholar]
  114. Carr EL, Kelman A, Wu GS, Gopaul R, Senkevitch E. 114.  et al. 2010. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J. Immunol. 1851037–44 [Google Scholar]
  115. Crotty S. 115.  2014. T follicular helper cell differentiation, function, and roles in disease. Immunity 41529–42 [Google Scholar]
  116. Oestreich KJ, Read KA, Gilbertson SE, Hough KP, McDonald PW. 116.  et al. 2014. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 15957–64 [Google Scholar]
  117. Ray JP, Staron MM, Shyer JA, Ho P-C, Marshall HD. 117.  et al. 2015. The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43690–702 [Google Scholar]
  118. Zeng H, Cohen S, Guy C, Shrestha S, Neale G. 118.  et al. 2016. mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity 45540–54 [Google Scholar]
  119. Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S. 119.  et al. 2014. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med.20:1327–33 Erratum. 2015 Nat. Med. 21414 [Google Scholar]
  120. Gaffen SL, Jain R, Garg AV, Cua DJ. 120.  2014. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14585–600 [Google Scholar]
  121. Endo Y, Asou HK, Matsugae N, Hirahara K, Shinoda K. 121.  et al. 2015. Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1. Cell Rep 121042–55 [Google Scholar]
  122. Raha S, Raud B, Oberdörfer L, Castro CN, Schreder A. 122.  et al. 2016. Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease. Eur. J. Immunol. 462233–38 [Google Scholar]
  123. Ye J, DeBose-Boyd RA. 123.  2011. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb. Perspect. Biol. 3a004754 [Google Scholar]
  124. Angela M, Endo Y, Asou HK, Yamamoto T, Tumes DJ. 124.  et al. 2016. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells. Nat. Commun. 713683 [Google Scholar]
  125. Muroski ME, Miska J, Chang AL, Zhang P, Rashidi A. 125.  et al. 2017. Fatty acid uptake in T cell subsets using a quantum dot fatty acid conjugate. Sci. Rep. 75790 [Google Scholar]
  126. Hu X, Wang Y, Hao L-Y, Liu X, Lesch CA. 126.  et al. 2015. Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists. Nat. Chem. Biol. 11141–47 Corrigendum. 2015 Nat. Chem. Biol. 11741 [Google Scholar]
  127. Santori FR, Huang P, van de Pavert SA, Douglass EF, Leaver DJ. 127.  et al. 2015. Identification of natural RORγ ligands that regulate the development of lymphoid cells. Cell Metab 21286–97 [Google Scholar]
  128. Wang C, Yosef N, Gaublomme J, Wu C, Lee Y. 128.  et al. 2015. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 1631413–27 [Google Scholar]
  129. Makki K, Froguel P, Wolowczuk I. 129.  2013. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013139239 [Google Scholar]
  130. Saucillo DC, Gerriets VA, Sheng J, Rathmell JC, MacIver NJ. 130.  2014. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J. Immunol. 192136–44 [Google Scholar]
  131. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. 131.  2006. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J. Immunol. 1767745–52 [Google Scholar]
  132. Reis BS, Lee K, Fanok MH, Mascaraque C, Amoury M. 132.  et al. 2015. Leptin receptor signaling in T cells is required for Th17 differentiation. J. Immunol. 1945253–60 [Google Scholar]
  133. Gerriets VA, Danzaki K, Kishton RJ, Eisner W, Nichols AG. 133.  et al. 2016. Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity. Eur. J. Immunol. 461970–83 [Google Scholar]
  134. De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S. 134.  et al. 2007. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26241–55 [Google Scholar]
  135. Newton R, Priyadharshini B, Turka LA. 135.  2016. Immunometabolism of regulatory T cells. Nat. Immunol. 17618–25 [Google Scholar]
  136. Travis MA, Sheppard D. 136.  2014. TGF-β activation and function in immunity. Annu. Rev. Immunol. 3251–82 [Google Scholar]
  137. Xie M, Zhang D, Dyck JR, Li Y, Zhang H. 137.  et al. 2006. A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. PNAS 10317378–83 [Google Scholar]
  138. Gualdoni GA, Mayer KA, Goschl L, Boucheron N, Ellmeier W, Zlabinger GJ. 138.  2016. The AMP analog AICAR modulates the Treg/Th17 axis through enhancement of fatty acid oxidation. FASEB J 303800–9 [Google Scholar]
  139. He N, Fan W, Henriquez B, Yu RT, Atkins AR. 139.  et al. 2017. Metabolic control of regulatory T cell (Treg) survival and function by Lkb1. PNAS 11412542–47 [Google Scholar]
  140. Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J. 140.  et al. 2015. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16188–96 [Google Scholar]
  141. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. 141.  2015. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat. Immunol. 16178–87 [Google Scholar]
  142. Sharma MD, Shinde R, McGaha TL, Huang L, Holmgaard RB. 142.  et al. 2015. The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment. Sci. Adv. 1e1500845 [Google Scholar]
  143. Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H. 143.  2013. mTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499485–90 [Google Scholar]
  144. Forero-Peña DA, Gutierrez FRS. 144.  2013. Statins as modulators of regulatory T-cell biology. Mediators Inflamm 2013167086 [Google Scholar]
  145. De Rosa V, Galgani M, Porcellini A, Colamatteo A, Santopaolo M. 145.  et al. 2015. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 161174–84 [Google Scholar]
  146. Wei J, Long L, Yang K, Guy C, Shrestha S. 146.  et al. 2016. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17277–85 [Google Scholar]
  147. Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L. 147.  et al. 2017. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab 251282–93.e7 [Google Scholar]
  148. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V. 148.  et al. 2016. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. Immunity 44406–21 Correction. 2016 Immunity 44712 [Google Scholar]
  149. Gerriets VA, Kishton RJ, Johnson MO, Cohen S, Siska PJ. 149.  et al. 2016. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nature Immunol 171459–66 [Google Scholar]
  150. Kishore M, Cheung KCP, Fu H, Bonacina F, Wang G. 150.  et al. 2017. Regulatory T cell migration is dependent on glucokinase-mediated glycolysis. Immunity 47875–89.e10 [Google Scholar]
  151. Kolodin D, van Panhuys N, Li C, Magnuson AM, Cipolletta D. 151.  et al. 2015. Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metab 21543–57 [Google Scholar]
  152. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J. 152.  et al. 2012. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486549–53 [Google Scholar]
  153. Munn DH, Bronte V. 153.  2016. Immune suppressive mechanisms in the tumor microenvironment. Curr. Opin. Immunol. 391–6 [Google Scholar]
  154. Maj T, Wang W, Crespo J, Zhang H, Wang W. 154.  et al. 2017. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat. Immunol. 181332–41 [Google Scholar]
  155. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H. 155.  et al. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460103–7 [Google Scholar]
  156. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA. 156.  et al. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460108–12 [Google Scholar]
  157. Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG. 157.  et al. 2013. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Investig. 1234479–88 [Google Scholar]
  158. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM. 158.  et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 171290–97 [Google Scholar]
  159. Sukumar M, Liu J, Mehta GU, Patel SJ, Roychoudhuri R. 159.  et al. 2016. Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy. Cell Metab 2363–76 [Google Scholar]
  160. Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A. 160.  et al. 2015. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res 75296–305 [Google Scholar]
  161. van der Windt GJW, Everts B, Chang C-H, Curtis JD, Freitas TC. 161.  et al. 2012. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 3668–78 [Google Scholar]
  162. Pfleger J, He M, Abdellatif M. 162.  2015. Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival. Cell Death Dis 6e1835 [Google Scholar]
  163. Rolf J, Zarrouk M, Finlay DK, Foretz M, Viollet B, Cantrell DA. 163.  2013. AMPKα1: a glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 43889–96 [Google Scholar]
  164. Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug GR. 164.  et al. 2016. The immune-metabolic basis of effector memory CD4+ T cell function under hypoxic conditions. J. Immunol. 196106–14 [Google Scholar]
  165. Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R. 165.  et al. 2013. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155160–71 [Google Scholar]
  166. Klein Geltink RI, O'Sullivan D, Corrado M, Bremser A, Buck MD. 166.  et al. 2017. Mitochondrial priming by CD28. Cell 171385–97.e11 [Google Scholar]
  167. Champagne DP, Hatle KM, Fortner KA, D'Alessandro A, Thornton TM. 167.  et al. 2016. Fine-tuning of CD8+ T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus. Immunity 441299–311 [Google Scholar]
  168. Lochner M, Berod L, Sparwasser T. 168.  2015. Fatty acid metabolism in the regulation of T cell function. Trends Immunol 3681–91 [Google Scholar]
  169. Cui G, Staron MM, Gray SM, Ho PC, Amezquita RA. 169.  et al. 2015. IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell 161750–61 [Google Scholar]
  170. Pan Y, Tian T, Park CO, Lofftus SY, Mei S. 170.  et al. 2017. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543252–56 [Google Scholar]
  171. O'Sullivan D, Pearce EL. 171.  2015. Targeting T cell metabolism for therapy. Trends Immunol 3671–80 [Google Scholar]
  172. Minn AJ, Wherry EJ. 172.  2016. Combination cancer therapies with immune checkpoint blockade: convergence on interferon signaling. Cell 165272–75 [Google Scholar]
  173. Swart M, Verbrugge I, Beltman JB. 173.  2016. Combination approaches with immune-checkpoint blockade in cancer therapy. Front. Oncol. 6233 [Google Scholar]
  174. Byun DJ, Wolchok JD, Rosenberg LM, Girotra M. 174.  2017. Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies. Nat. Rev. Endocrinol. 13195–207 [Google Scholar]
  175. Lim WA, June CH. 175.  2017. The principles of engineering immune cells to treat cancer. Cell 168724–40 [Google Scholar]
  176. Yu S, Li A, Liu Q, Li T, Yuan X. 176.  et al. 2017. Chimeric antigen receptor T cells: a novel therapy for solid tumors. J. Hematol. Oncol. 1078 [Google Scholar]
  177. Kawalekar OU, O'Connor RS, Fraietta JA, Guo L, McGettigan SE. 177.  et al. 2016. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44380–90 [Google Scholar]
  178. Cherkassky L, Morello A, Villena-Vargas J, Feng Y, Dimitrov DS. 178.  et al. 2016. Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. J. Clin. Investig. 1263130–44 [Google Scholar]
  179. Crompton JG, Sukumar M, Restifo NP. 179.  2016. Targeting Akt in cell transfer immunotherapy for cancer. Oncoimmunology 5e1014776 [Google Scholar]
  180. Zheng Y, Delgoffe GM, Meyer CF, Chan W, Powell JD. 180.  2009. Anergic T cells are metabolically anergic. J. Immunol. 1836095–101 [Google Scholar]
  181. Nguyen DX, Bos PD, Massague J. 181.  2009. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9274–84 [Google Scholar]
  182. Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M. 182.  et al. 2016. Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell 1661117–31.e14 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error